Chengyong Lei
-
- Epigenetics and DNA Methylation 4
- Cancer-related gene regulation 2
-
- Cancer Cells and Metastasis 5
- Colorectal Cancer Screening and Detection 2
-
- Hippo pathway signaling and YAP/TAZ 2
-
- Prostate Cancer Diagnosis and Treatment 2
-
- Cancer Research and Treatments 5
-
- Immunotherapy and Immune Responses 4
- Co-authors
- Yongtong ZhuWanlong TanHongyi WangShidong LvWei WangShiyu PangYang LuoWeiyi Fang
- Partner nations
- ChinaUnited KingdomMacao
In The Last Decade
Chengyong Lei
17 papers receiving 429 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 136
- Molecular Biology 294
- Oncology 94
- Cell Biology 43
- Pulmonary and Respiratory Medicine 74
Countries citing papers authored by Chengyong Lei
This map shows the geographic impact of Chengyong Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengyong Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengyong Lei more than expected).
Fields of papers citing papers by Chengyong Lei
This network shows the impact of papers produced by Chengyong Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengyong Lei. The network helps show where Chengyong Lei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chengyong Lei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2022 | 5 | |
| 3 | 2022 | 2 | |
| 4 | 2019 | 75 | |
| 5 | 2019 | 1 | |
| 6 | 2018 | 19 | |
| 7 | 2018 | 4 | |
| 8 | 2017 | 90 | |
| 9 | [Three-dimensional versus two-dimensional imaging systems in laparoscopic radical prostatectomy for prostate cancer: a retrospective cohort study]. | 2017 | 3 |
| 10 | 2017 | 34 | |
| 11 | 2016 | 17 | |
| 12 | 2015 | 46 | |
| 13 | 2015 | 11 | |
| 14 | 2015 | 51 | |
| 15 | 2014 | 26 | |
| 16 | Red and processed meat intake and risk of bladder cancer: a meta-analysis. | 2014 | 29 |
| 17 | 2013 | 15 | |
| 18 | 1989 | 5 |
About Chengyong Lei
Chengyong Lei is a scholar working on Biotechnology, Oncology and Cancer Research, having authored 18 papers that have together received 433 indexed citations. Recurring topics across this work include Cancer Research and Treatments (5 papers), Cancer Cells and Metastasis (5 papers), Epigenetics and DNA Methylation (4 papers), Immunotherapy and Immune Responses (4 papers), Colorectal Cancer Screening and Detection (2 papers), Prostate Cancer Diagnosis and Treatment (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Cancer Research (136 citations), Molecular Biology (294 citations) and Oncology (94 citations). Chengyong Lei has collaborated with scholars based in China, United Kingdom and Macao. Frequent co-authors include Yongtong Zhu, Wanlong Tan, Hongyi Wang, Shidong Lv, Wei Wang, Shiyu Pang, Yang Luo, Wei Wang, Weiyi Fang and Sansan Chen. Their work appears in journals such as Oncogene, The Journal of Pathology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.